The blood of mammalian species contains a component which inactivates endotoxins in vitro (1). This endotoxin-detoxifying component (EDC) is identified by attributes which distinguish it from other substances in blood of known biologic activity (2, 3). Following appropriate interaction in vitro with this component, endotoxins from gram-negative bacteria are so altered that they no longer elicit such characteristic host reactions as the production of antibody (4), tumor damage, local skin reactivity and fatal shock. Bacterial endotoxins elicit the same host reactions which are evoked by the intact gram-negative bacilli from which they are isolated (5). It was therefore expected that the endotoxin in its native state on the bacterial surface would also be susceptible to inactivation by an agent with the distinctive properties of EDC.
(Submitted for publication August 18, 1959; accepted October 2, 1959) The blood of mammalian species contains a component which inactivates endotoxins in vitro (1) . This endotoxin-detoxifying component (EDC) is identified by attributes which distinguish it from other substances in blood of known biologic activity (2, 3) . Following appropriate interaction in vitro with this component, endotoxins from gram-negative bacteria are so altered that they no longer elicit such characteristic host reactions as the production of antibody (4), tumor damage, local skin reactivity and fatal shock. Bacterial endotoxins elicit the same host reactions which are evoked by the intact gram-negative bacilli from which they are isolated (5) . It was therefore expected that the endotoxin in its native state on the bacterial surface would also be susceptible to inactivation by an agent with the distinctive properties of EDC.
This communication records the results of experiments which show that, by appropriate interaction in vitro with serum, it is possible to eliminate characteristic host-reactive properties of a typical gram-negative species. In the course of these studies with Salmonella typhosa, EDC was found to inactivate the endotoxin of bacilli which had been killed by heat or by chemical means, but not that in viable organisms; however, in the latter the endotoxin was inactivated by the serum bactericidal system consisting of antibody and complement. It is thus evident that two humoral mechanisms can function to inactivate the endotoxic properties of intact gram-negative bacilli.
MATERIALS AND METHODS
Collection of serum. Pooled serum specimens were prepared from the blood (10 or more individual donors) of mice, guinea pigs and rats. In some experiments human serum, pooled from 100 or more individuals, was employed. In other instances, animal and human serum samples were individual specimens. All serum samples * Present address: Children's Hospital, Boston, Mass.
were stored at -20°C in sealed glass ampoules. Plasma was obtained from blood collected in heparin, sodium citrate or ACD solution,' and by passage of blood through a Fenwal ion exchange pack; the latter is referred to as "resin-treated" plasma.
Preparation of complemnent reagentts. The reagents were prepared by standard methods (6) and each was checked for absence of hemolytic and/or bactericidal activity. Human serum was made deficient in the first component of complement (C'1) by dialysis against acetate buffer (pH 5.5, u = 0.02) for 48 hours at 40 C. The serum was then centrifuged, and the supernatant fluid was adjusted to the desired pH and ionic strength with NaOH and NaCl. This reagent, deficient in C'1, is referred to as RI.
The precipitate obtained in this way (by dialysis and centrifugation) was washed twice with the dialyzing buffer and taken up in saline to original volume. This reagent is deficient in the second component of complement (C'2) and is referred to as R2.
Human serum was made deficient in the third component of complement (C'3) by incubation for 1 hour at 370 C with zymosan (Fleischmann; 2 mg per ml serum).
This reagent is referred to as R3.
The fourth component of complement (C'4) was inactivated by incubation of human serum containing 0.025 M hydrazine for 1 hour at 370 C. The product, deficient in C'4, is referred to as R4. Sera which had been heated for onie-half hour in a water bath at 520 or 560 C are designated 520 C-serum and 56°C-serum.
Human serum, deficient in properdin (RP), was prepared by incubation with zymosan (Fleischmann; 2 mg per ml) for one hour at 17°C (7) . This reagent retained the full hemolytic activity of the serum; its bactericidal activity against S. typhosa 0901 was also fully retained.
Assay of serum bactericidal activity. The bactericidal activity of serum and of the serum reagents was determined by adding the standard number of test organisms to dilutions of the material to be assayed. The mixtures were incubated for 1 hour at 370 C, serial decimal dilutions were then made, and aliquots of each were plated in duplicate on meat extract agar, to ascertain the number of viable organisms remaining in the reaction mixture.
Preparationt of bacterial suspentsions. Meat extract 1 Twenty-two g trisodium citrate, 8 g citric acid, and 25 g dextrose per L of water; 15 ml of this solution was added to each 100 ml of whole blood. agar plates were inoculated with S. typhosa 0901 and incubated at 370 C for 18 hours. The growth was harvested in saline and seeded heavily on the surface of veal-infusion agar plates. Following incubation for 5 hours at 370 C the bacteria, in the log phase of growth, were again harvested in saline. The optical density of appropriate dilutions of this harvest was read in a KlettSummerson photometer and an estimate of the concentrations of viable organisms was made by plotting photometric readings on a standard curve of optical density vs. viable count. Serial dilutions of the suspension were plated out on meat extract agar to verify, by viable count, the bacterial concentration estimated by photometry.
Suspensions of killed organisms were prepared by heating aliquots of the S. typhosa suspension in a water bath at 560 C for 1 hour in stoppered tubes or by incubating the suspension at 370 C for 2 hours with merthiolate in a final concentration of 0.1 per cent.
Interaction of serutm and S. typhosa. For determination of capacity of serum to inactivate the endotoxin of S. tvphosa, various dilutions of serum were incubated for 1 hour at 370 C with a standard number of organisms. Quantities of reactants employed were such as would provide sufficient material for subsequent test in animals; in these tests each mouse routinely received 6 X 107 organisms. One ml of a suspension containing 6 X 10' organisms per ml, enough for test in 10 mice, was incubated with 2 ml of the desired dilution of serum. After incubation the volume was made up to 5 ml with sterile saline; each mouse received 0.5 ml of the reaction mixture, i.e., 6 X 107 organisms.
The variable in these tests was the dilution of serum (or serum reagent) incubated with a constant number of bacilli. Although the procedure outlined above is given in terms of the quantity required for a group of 10 mice, the data presented in this report are presented in terms of the quantity administered per mouse.
Assay of endotoxic potency of typhoid bacilli and its inactivation by serutm. Sarcoma 37 was implanted into the thigh muscle of young CAF1 mice (2 to 3 months old); 0.05 ml of a tumor mash was the amount injected. Six days later, 200 mice bearing such implants were randomly distributed into groups of 10 each. Each set of bioassays included two control groups: the first consisted of 10 untreated mice, to disclose the extent of spontaneous hemorrhage or necrosis in the tumors of the set; the second one consisted of 10 mice which had been given the standard dose of 6 X 10? typhoid bacilli for estimation of the level of responsiveness of the set of tumors to endotoxin (8) . This number of organisms (6 X 10') was sufficient to induce marked hemorrhage and necrosis in the tumors within 24 hours, but it was small enough to permit the diminution or elimination of this endotoxic activity to be readily detected. The mice were injected intraperitoneally with 0.5 ml aliquots of the test mixtures described above. On the following day the animals were sacrificed and the tumors bisected and examined for induced tumor damage. The experimental groups were scored on the basis of comparison with the two control groups. When no tumor damage was evident it was obvious that the bacterial endotoxin had been inactivated. Intermediate degrees of tumor damage showed that partial inactivation had occurred. When tumor damage was equal in severity to that in the control group given untreated bacteria, no significant inactivation of the bacterial endotoxin had occurred.
Assay of antigenicity int rabbits. The effect of serum reagents on the antigenicity of S. typhosa 0901 was determined by incubation of the reagents with the standard dose (10 X 10' organisms) for 1 hour at 370 C. The number of bacilli and the test conditions were the same for experiments with either killed or viable organisms. Amounts of reactants were chosen to be sufficient for test in groups of rabbits (5 animals per group). After incubation, each mixture was diluted with an appropriate amount of saline so that each animal received intravenously 10 X 10' serum-reacted bacilli in a volume of 2.0 ml. Each experiment included a control group of rabbits given the same dose of bacilli incubated in saline. Rabbits of a single breed (New Zealand albino females, weighing 2 to 2.5 kg) from a single source (National Institutes of Health animal unit) were employed throughout. Six days after the single intravenous immunizing injection the animals were bled and the typhoid 0 agglutinin titers of the sera were determined. For the agglutination tests, equal volumes of serial twofold dilutions of rabbit serum and a suspension of heat-killed S. typhosa 0901 (1 X 10' organisms per ml) were incubated for 18 hours at 520 C. Agglutination was read macroscopically, and the highest serum dilution in which agglutination was clearly visible was recorded as the titer.
RESULTS
The choice of a host indicator reaction for the assay of endotoxic potency is of prime importance in determining whether the endotoxin of intact bacilli is altered by agents in normal blood. Our previous work on the inactivation of purified endotoxin by EDC indicated that the most sensitive and consistent evidence of alterations in endotoxin was provided by indicator systems such as the induction of hemorrhagic necrosis in sarcoma implants of mice and the production of antibody in rabbits. Accordingly, these were the methods of choice for the present work. The basic observations on the detoxification of intact bacilli, which constitute the first part of this experimental section, were made with the use of the tumor damage assay. Then the requirements for such a detoxifying effect were further substantiated by determining changes in the antigenic properties of these bacilli.
Induction of tumor damage by heat-killed bacilli. Typhoid bacilli, killed by exposure to 560 C for 60 minutes, were found to induce tumor damage in a manner qualitatively indistinguishable from that of the endotoxin isolated from the same organisms. The minimal number of bacilli which induced significant hemorrhagic necrosis in the sarcoma implants was in the order of 30 million organisms, but 60 or 100 million organisms were routinely employed to assure the consistent and uniform induction of tumor damage of appropriate severity. Inactivation of heat-killed bacilli. Incubation of heat-killed bacilli with citrated human plasma rendered these organisms inactive as tumor-damaging agents. Matched specimens of serum and plasma from a single donor were titrated for their inactivating potency. It was found that serum and heparinized plasma had little effect on the tumordamaging activity of the killed bacilli, whereas citrated and resin-treated plasma were highly potent. These experiments indicated that divalent cation suppressed the effect of this agent in the blood. Evidence that isolated endotoxin and heatkilled bacilli are inactivated by the same agent is presented in Table I . The conditions of time and temperature required to inactivate the bacilli were similar to those previously established for the alteration of isolated endotoxin by EDC. Furthermore, in both instances, inactivation failed to take place when the reactants were administered separately or were merely admixed and injected without any incubation. Experiments with typhoid bacilli, which had been killed with merthiolate, gave identical results. These data show that the endotoxin of killed typhoid bacilli is inactivated by an agent in blood which, like EDC, can be suppressed by divalent cation.
Induction of tumor damage by viable bacilli. The tumor-damaging potency of aliquots of a harvest of S. typhosa were titrated; it was found that 15 million viable organisms produced significant tumor damage, whereas 30 million of the heat-killed bacilli were required for the same effect. To assure a uniformly high degree of hemorrhagic necrosis the quantity of viable organisms routinely employed for induction of tumor damage was increased to 60 million. As will be brought out later in this report, no significant multiplication of these organisms occurs in the peritoneal cavity during a period of at least four hours after injection. Moreover, pretreatment of the mice with chloramphenicol did not affect the induction of tumor damage by 60 million organisms. These findings indicate that the observed tumor damage was evoked primarily by the number of bacteria which were injected and was not the result of further bacterial growth in the mouse peritoneal cavity.
Inactivation of viable bacilli. Pilot experiments in which viable bacilli were incubated with human serum or plasma showed that the tumor-damaging effect of these bacilli could be eliminated by serum. However, it soon became evident that this effect was not correlated with EDC activity. For example, human serum, to which calcium was added to suppress EDC activity, was still effective in eliminating the tumor-damaging activity of the organisms. Guinea pig serum, which likewise man-ifested no EDC activity, was equally potent. On the other hand mouse citrated plasma with good EDC activity was without effect on the endotoxin of viable bacilli. The findings presented in Table  II emphasize that the requirements for the inactivation of viable bacilli are quite different from those for the inactivation of bacilli killed by heat.
Serum bactericidal activity and inactivation of viable bacilli. Specimens of fresh serum from eight animal species were interacted with viable S. typhosa to determine whether they were capable of abolishing tumor-damaging activity. With the exception of mouse serum, sera of all species were effective. This conspicuous lack of effect of mouse serum (9) on the tumor-damaging potency of viable organisms provided the first indication that only serum with bactericidal activity was capable of bringing about this change. Rabbit serum was the least potent, followed by horse, rat, sheep, dog, guinea pig and human sera, in increasing order of potency. Guinea pig and human sera consistently exhibited the most pronounced effect. The fact that many of these sera had previously been shown to lack EDC activity was further evidence that another agent was involved in the inactivation of viable bacilli.
These sera were examined for their in vitro bactericidal activity against the test organism. Although a precise correlation was not established, the in vitro bactericidal potency and the capability of these sera to inactivate the endotoxic effects of viable typhoid bacilli were comparable. Human and guinea pig sera were the most potent in both situations whereas rabbit serum was the least effective. t Prepared by dialysis.
in vivo. It was found that-. serum rendered deficient in one or another of the components of complement, and thus no longer bactericidal, was still capable of inactivating the tumor-damaging capacity of the organisms following intraperitoneal injection into mice (Table IV) . Rl and R4 were as effective as whole serum in their ability to inactivate the tumor-damaging potency of the viable bacilli. On the other hand, R2 and R3 no longer exhibited any activity in this regard, and serum exposed to 560 C for 30 minutes was likewise ineffective. However, an R2 prepared by heating serum at 520 C for an equal length of time still was capable of eliminating tumor-damaging activity of viable organisms. Heating of serum at 56' C is known to render it completely deficient in C'1 and C'2, whereas heating at 520 C results in complete loss of only C'2 (6) . Evidence that these complement reagents were producing their effect in vivo was obtained in the experiment summarized in Table V . When the reaction of serum and viable organisms was carried out in an in vitro environment, neither the reaction mixture nor the bacteria removed by centrifugation produced tumor damage. On the other hand, incubation of organisms in serum rendered nonbactericidal by heating at 52°C yielded cells with essentially undiminished endotoxic potency. It is seen from this experiment that no loss of capacity to elicit tumor damage occurs after incubation of viable bacilli in nonbactericidal serum reagents. Thus the effectiveness of such reagents as Ri, R4 and 520 Cheated serum was due to events which occurred after injection into the mouse peritoneal cavity.
Limiting interval for inactivation in vivo of viable bacilli by serum. It was presumed that the effective complement reagents supplemented, and thus accelerated, the mouse's own mechanisms for coping with the injected bacteria. It was further reasoned that the tumor-damage reaction was fixed within a certain time limit. Thus, the presence or absence of effect by these various complement reagents would depend upon their ability to produce accelerated killing of these organisms in the peritoneal cavity of the mouse. To ascertain the validity of this assumption, the following experiment was performed. The Controls (saline) 9.1 * These products were incubated at 370 C for 1 hour with 10 X 10s S. typhosa after which serial dilutions of the reaction mixtures were plated for viable count.
duction in bacterial numbers which occurred within one hour. This is the time interval in which 520 C-heated serum, or any other effective complement reagent, must be given to eliminate the tumor-damaging activity of the bacteria. Bactericidal activity of mouse serum combined with human complement reagents. Normal mouse serum was combined with one or another of the complement-deficient reagents, and these combinations were examined for their bactericidal activity in order to determine whether these in vivo bactericidal effects could be duplicated in vitro. The results of such an experiment, given in Table VIII, show that nonbactericidal mouse serum, combined with inactivated (560 C) human serum or R3 was not bactericidal. However, when mouse serum was added to human serum which had been heated at 520 C, pronounced bactericidal activity was obtained; as little as 0.05 ml of the 520 Cserum with 0.2 ml of mouse serum sufficed to elicit significant bactericidal activity. On the other hand, such heated human serum, combined with mouse serum which had been similarly heated at 520 C, did not provide a bactericidal combination.
From these data, and those obtained in the preceding experiments, it became clear that those complement-deficient reagents which were effective in vivo were equally effective as bactericidal agents when combined in vitro with mouse serum. Ineffectiveness of complement reagents in the levan-treated mouse. It has been reported (10) that the intravenous injection of levan inhibits the transcapillary transfer of humoral factors of the mouse and thereby permits the unhindered growth of intraperitoneally-injected gram-negative bacteria. This experimental model was utilized to show that human complement reagents were effective in vivo only by virtue of supplementation with humoral factors present in the mouse. Tumor-bearing mice were given 3 mg of levan2 intravenously, followed by the intraperitoneal injection of 2 x 106 S. typhosa. Mice so treated exhibited marked tumor damage, whereas nonlevanized, tumor-bearing mice did not react to this small dose of bacilli. Reagents such as 520 C-serum and R4 prevented tumor damage induced by as many as 6 x 107 bacilli in nonlevanized mice. However, these reagents were ineffective in mice which had been prepared with levan, whereas whole human serum was effective. These data offer further support for the view that the efficacy of certain complement-deficient reagents is dependent upon the transfer of humoral factors from the mouse circulation to the peritoneal cavity.
Antigenicity for rabbits of viable and killed S. typhosa. The production of antibody by rabbits in response to S. typhosa was employed as an indicator of host reactivity to endotoxin in order to extend the previous observations on the changes produced in the endotoxin of intact bacilli by humoral agents. Groups of rabbits were given single intravenous injections of viable or of heat-killed bacilli prepared from a common harvest. As little as 0.1 x 108 organisms sufficed to evoke measurable levels of antibody. As the immunizing dose was increased by tenfold increments the agglutinin titers rose sharply. Mean titers for rabbits receiving 1 x 106 killed organisms was 1: 280 and that for viable bacilli was 1: 720; 10 x 108 gave mean titers of 1: 1,350 for killed bacilli and Elimination of the antigenicity of killed S. typhosa by EDC. It was shown in a preceding section that the endotoxin of killed typhoid bacilli is inactivated by a humoral agent with the distinctive attributes of EDC. EDC activity is readily suppressed by divalent cations such as Ca++, Mg++, Mn++ and Ba++ and requires certain anions to exert its effect on endotoxin (3). These characteristics were utilized to demonstrate that this component likewise affected the antigenicity of heat-killed typhoid bacilli. The antibody response of rabbits to such organisms, which had been incubated at 370 C for one hour with one or another source of EDC activity, was determined. The same results were obtained in the two experiments performed, each involving 65 rabbits. The data from one of these are given in Table IX . It is evident that elimination of antigenicity was effected by those reagents known to have EDC activity, i.e., citrated (ACD) plasma, such plasma as had been dialyzed and then supplemented with sodium citrate, and serum in which the divalent cation was bound with a chelating agents such as EDTA (4) . On the other hand, the bacilli which had been incubated in the very same plasma or serum in which EDC had been suppressed by the prior addition of calcium, or by dialysis against water, had undiminished antigenic potency.
Inactivation of antigenicity of viable bacilli by the complement system. Viable typhoid bacilli after interaction with fresh human serum in vitro no longer elicited high levels of typhoid agglutinins in rabbits. To determine the factors in serum responsible for this elimination of antigenicity, viable bacilli were interacted for one hour at 370 C with human serum which had been rendered deficient in one or another of the components of complement. Each reaction mixture was examined in parallel in bactericidal and antigenicity tests. One such experiment, summarized in Table X, shows that fresh serum, which is highly effective in rendering the bacilli nonviable and nonantigenic, no longer exerts this effect when made deficient in divalent cation or any of the components of complement. The interrelationship of these biologic effects of serum was further substantiated in studying the rate of the reaction. Human serum and a suspension of viable bacilli were mixed in a water bath at 4°C and aliquots were transferred to a 370 C bath in which they remained for varying intervals ranging from 5 to 60 minutes. The reaction was terminated by returning the aliquots to the 40 C bath, after which the viable count and the antigenicity of the It has been proposed that the somatic antigen on the bacterial surface is the key substrate for serum bactericidal activity (11) . However. no direct evidence has heretofore been obtained to substantiate this proposal. The present work, which shows that inactivation of endotoxin is intimately associated with the killing of S. typhosa by the normal serum bactericidal mechanism, constitutes evidence that indirectly supports this view. These alterations in the endotoxin of the viable bacillus, which can readily be measured, may offer special advantages for further delineation of the complex sequence of events in the killing of bacteria by serum. It has been reported recently that fresh serum can produce morphological alterations in the cell wall of Salmonella (12) and Shigella species (13) which results in their conversion to spheroplasts. It has not been established that the formation of these spheroplasts is an essential step in the process by which serum kills these bacilli. The essential factors and conditions of the serum bactericidal mechanism appear to be less complex than are the requirements for the serum conversion of typhoid bacilli to spheroplasts. Although the inactivation of endotoxic activity undoubtedly occurs under these more complex circumstances, it also can be effected under conditions which do not favor spheroplast formation. Therefore, there is, at present, no evidence that would directly relate the inactivation of the bacterial endotoxin to the changes in the cell wall which result in spheroplast formation.
We have previously discussed the advantages and limitations of the various host responses to endotoxin with regard to their use for the assay of endotoxin and thereby for the measurement of alterations produced in endotoxin by biologic agents (2) . It was pointed out that of the considerable array of reactions in the mammalian host which are known to be elicited by endotoxin very few provide discriminating quantitation and acceptable consistency. The two host responses to endotoxin which have been utilized in the present work had been found to meet these requirements in related studies. Furthermore, the changes detected with these two systems were shown to be equally applicable to still other reactions of the host. Accordingly, the changes in the endotoxin of intact S. typhosa which have been measured by loss of antigenicity, and the capacity to induce tumor damage, are considered to be indicative of major alterations in this complex. Even though the end products of the interactions are equally ineffective in eliciting host responses, it does not necessarily follow that EDC alters the endotoxic complex in the same way as does the complement-antibody system. The nature of the changes in the endotoxic complex brought about by either of these systems is presently unknown.
In the course of these studies other information has been obtained which has little direct bearing on the primary issues under consideration. Inasinuch as these incidental findings contribute to areas which have attracted interest they are summarized briefly: a) In the past it was not possible to determine precisely the time, after injection of polysaccharide, when the pattern of events leading to tu--mor damage by the injected endotoxin became irreversible (14) . In the present work, the use of viable typhoid organisms as a source of endotoxin was advantageous in that it was possible to inactivate or detoxify the bacilli by the separate administration of serum. The sequence of events leading to the production of hemorrhagic necrosis could be interrupted by the injection of serum within an interval of one hour after the bacilli. After this time interval the administration of serum no longer influenced the ultimate outcome despite the absence of any change detected in the tumor at the time the serum was given.
b) Past evidence has led to the assumption that mouse serum is deficient in both the second and third components of complement (15) , to which has been attributed the lack of bactericidal and hemolytic activity of such serum in vitro. The present report presents further evidence in support of this contention, in that the addition to mouse serum of either R2 or R3, prepared from human serum by standard methods, failed to provide a combination with bactericidal activity. However, human serum from which C'2 had been eliminated by heating (one-half hour at 520 C) exhibited highly effective bactericidal activity when combined with mouse serum. Thus, different results were obtained on supplementing mouse serum depending on the method of preparation of R2. However, when such heated human serum was combined with mouse serum which had also been heated at 52°C, bactericidal bits. The endotoxic activity of typhoid bacilli killed by heat or by chemical treatment was inactivated by endotoxin-detoxifying component (EDC), the same agent previously shown to affect isolated endotoxin, but was not inactivated by antibody and complement. In contrast, the endotoxic activity of viable bacilli was not affected by EDC but was eliminated by antibody and complement, the recognized bactericidal system of normal serum. Viability was thus the critical factor in determining which of these two humoral systems exerted an effect on the endotoxin of typhoid bacilli.
